Analysis of Changes in Blood Glucose Using a Continuous Blood Glucose Monitoring After Spinal Epidural Nerve Block with Steroids in Patients with Low Back Pain
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Primary Endpoint
- Glucose change
Study Overview
Brief Summary
This study aims to investigate the effect of different doses of dexamethasone used in epidural nerve block procedures on blood sugar levels. Patients with spinal conditions such as stenosis or disc herniation will be enrolled. Blood glucose and HbA1c levels will be measured before the procedure, and participants will use continuous glucose monitoring devices for 2-3 days before the procedure. They will be randomly assigned to one of three groups: no dexamethasone, 5mg dexamethasone, or 7.5mg dexamethasone. Blood glucose will be monitored for one week after the procedure, and follow-up will be done two weeks later to assess pain and blood sugar data. This study will help determine how steroid doses affect blood sugar, especially in elderly patients, and provide more accurate information than previous studies.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Care Provider)
Eligibility Criteria
- Ages
- 19 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •patients need to epidural steroid injection for treating back pain
- •patients diagnosed with diabetes or prediabetes.
Exclusion Criteria
- •Patients with poorly controlled blood sugar.(HbA1c>8.5)
Arms & Interventions
dexamethasone dose-0
Intervention: Epidural steroid injection (ESI) (Procedure)
dexamethasone dose 5.0
Intervention: Epidural steroid injection (ESI) (Procedure)
dexamethasone dose-7.5
Intervention: Epidural steroid injection (ESI) (Procedure)
Outcomes
Primary Outcomes
Glucose change
Time Frame: glucose change between befor intervention and after for 7days.
Secondary Outcomes
No secondary outcomes reported
Investigators
Sung Hyun Lee
Kangbuk Samsung Hospital
Kangbuk Samsung Hospital
